demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
secondary prevention
potential COVID-19 treatments
adjuvant therapies
anticoagulant
rivaroxaban MICHELLE

0 studies excluded by filtering options 1